road manag
compel predictability/vis earn growth host
investor meet ceo jon ayer cfo brian corp
strategy/ir kerri bennett ir specialist galina hanson manag
highlight sustain leadership posit innov test
capabl competit global footprint robust expand
commerci strategi run ahead plan continu view
compel attract altern healthcar invest strong
custom retent healthi fundament backdrop contribut
greater predict visibl earn growth
re-affirmed guidanc boost lt view re-affirmed oper
guidanc org revenue bp oper margin
expans constant currenc maintain ep
ep move stronger revenu profit
support strong fundament continu innov global expans
matur sale forc effort tp move
higher view greater convict lt growth prospect catalyst
ep report potenti updat target investor
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
price jun rate outperform target price analyst erin wright
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
 close
global leader diagnost point-of-car equip
refer laboratori servic companion anim also
provid system diagnost livestock water qualiti
share gain refer laboratori point-of-car acceler
global expans greater contribut innov new product
launch technolog advanc greater expect
growth broader anim health industri fundament
stronger expect macroeconom fx headwind
increasingli global footprint less adoption/tract futur product
launch deterior veterinari health fundament
charl martineau univers toronto highlight manag
major updat meet manag
compar meet may see note buy momentum management
meet highlight highlight key theme discuss
exist product
perform well econom environ even
recessionari time-frame view sever lever pull despit
cyclic aspect veterinari industri note normal macro backdrop us
veterinari offic visit growth growth rang importantli
continu character fundament robust
relationship corpor chain veterinari hospit remain strong lead
innov space view relationship highli sticki
sophist test capabl offer key revenu driver advanc
highlight consist price power net price realiz past year
line provid manag
confid continu realiz annual price gain forese futur
compani
industry-lead product access veterinarian enhanc idxx
brand veterinari standard care
new sale forc traction run ahead plan may disclos add
field base sale repres bring total us sale forc rep
repres third sale forc increas sinc move direct importantli
increment invest associ ad sale forc alreadi reflect
guidanc note effort on-board new sale rep traction thereon
run ahead plan
vs snap guidanc risk-adjust rang potenti competit
impact abax recent rapid assay launch compet flagship
snap test howev manag note veterinarian tick-born area
highlight perform issu importantli american societi
rickettsiolog annual meet earlier month june unveil studi
sponsor cornel nc state identifi superior perform
snap rapid assay vs abaxiss recent launch compet test
diagnos relev vector-born diseas acknowledg idxx rapid assay
platform high-margin categori revenu inher vulner
competit potenti exacerb pend zoetis/abax transact latest
data help instil greater confid idxx competit posit despit recent
detail studi test relev vector-born infect includ lyme
plati heartworm shown figur result studi demonstr
superior sensit idxx test measur correct identif
posit diseas state diseas categori offer report
similar specif correct identif neg diseas state greater
figur studi rapid test american societi
meet american societi rickettsiolog compani data credit suiss estim
broadli acquisit abax could also lead distributor deemphas
among disrupt factor therefor repres potenti
sourc upsid idxx near term estim view
fecal snap upcom fecal snap test still slate estim januari
launch ahead all-import veterinari industri confer vmx jan
us focu fecal test build intern awar time
sdma combo slate juli launch
refer laboratori updatebuild capac groundbreak
new refer laboratori germani last week abil better
accommod build volum overnight oper vs current locat
consist may meet manag broadli deemphas competit
threat acquisit abax view signific valu larg
pharmaceut compani promot import diagnost global presenc
combin idxx industry-lead suit product could work idxx
advantag notabl manag downplay abil bundl pharmaceut
product diagnost highlight vast differ two purchas
decis veterinarian howev view could opportun
leverag sizeabl global sale footprint diagnost pipelin time also
focu product anim intern market view room
one player highli under-penetrated area deemphas direct
nt competit threat leadership posit fact like disrupt
zts/abax combin interestingli depict abaxi could repres
meaning opportun
stress potenti promot livestock diagnost anoth posit
histor accord larg anim health pharmaceut
compani deemphas signific diagnost favor vaccin anti-
infect addit manag believ abax instrument well-suit
success detect livestock infecti diseas requir advanc
technolog still categori broadli under-penetrated put perspect
livestock repres busi vast major ou leader
categori global
note manag also deemphas likelihood larg pharma anim
health compani merck anim health eli lilli elanco busi
enter diagnost space note intens competit necessari know-
critic sustain long term success regard acquir diagnost
compani access relev anim health data manag note market
anim health diagnost data pharmaceut compani much cheaper rate
premium requir purchas dognost player interestingli said work
boehring ingelheim legaci merial anim health busi
impress compani sophist data focu
compani mention price
